| Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer PJ Bates, DA Laber, DM Miller, SD Thomas, JO Trent Experimental and molecular pathology 86 (3), 151-164, 2009 | 930 | 2009 |
| A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma JE Rosenberg, RM Bambury, EM Van Allen, HA Drabkin, PN Lara, ... Investigational new drugs 32, 178-187, 2014 | 388 | 2014 |
| Rituximab‐induced interstitial lung disease SA Wagner, AC Mehta, DA Laber American journal of hematology 82 (10), 916-919, 2007 | 166 | 2007 |
| Clinical efficacy and toxicity of anti‐EGFR therapy in common cancers A Harandi, AS Zaidi, AM Stocker, DA Laber Journal of Oncology 2009 (1), 567486, 2009 | 144 | 2009 |
| The role of human papilloma virus in lung cancer: a review of the evidence A Rezazadeh, DA Laber, SJ Ghim, AB Jenson, G Kloecker The American journal of the medical sciences 338 (1), 64-67, 2009 | 88 | 2009 |
| Clinical spectrum of myelophthisis in cancer patients SN Makoni, DA Laber American journal of hematology 76 (1), 92-93, 2004 | 67 | 2004 |
| Argatroban for anticoagulation during cardiac surgery ME Martin, GH Kloecker, DA Laber European journal of haematology 78 (2), 161-166, 2007 | 59 | 2007 |
| Risk factors, classification, and staging of renal cell cancer DA Laber Medical Oncology 23, 443-454, 2006 | 54 | 2006 |
| Update on the first phase I study of AGRO100 in advanced cancer DA Laber, VR Sharma, L Bhupalam, B Taft, FJ Hendler, KM Barnhart Journal of Clinical Oncology 23 (16_suppl), 3064-3064, 2005 | 47 | 2005 |
| Mobilization of Hematopoietic Progenitor Cells by Yeast-Derived β-Glucan Requires Activation of Matrix Metalloproteinase-9 DE Cramer, S Wagner, B Li, J Liu, R Hansen, R Reca, W Wu, EZ Surma, ... Stem Cells 26 (5), 1231-1240, 2008 | 45 | 2008 |
| Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy JD Sandoval-Sus, F Mogollon-Duffo, A Patel, N Visweshwar, DA Laber, ... Journal for ImmunoTherapy of Cancer 5, 1-5, 2017 | 39 | 2017 |
| A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma DA Laber, RI Okeke, C Arce-Lara, BS Taft, CL Schonard, KM McMasters, ... Journal of cancer research and clinical oncology 132, 611-616, 2006 | 32 | 2006 |
| Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome MA Choudry, BK Moffett, DA Laber Annals of hematology 86, 233-237, 2007 | 31 | 2007 |
| Extended phase I study of AS1411 in renal and non-small cell lung cancers DA Laber, BS Taft, GH Kloecker, PJ Bates, JO Trent, DM Miller Journal of Clinical Oncology 24 (18_suppl), 13098-13098, 2006 | 31 | 2006 |
| Digitalis, a targeted therapy for cancer? MI Khan, JA Chesney, DA Laber, DM Miller The American journal of the medical sciences 337 (5), 355-359, 2009 | 29 | 2009 |
| Evolving paradigm in thrombophilia screening N Ashraf, N Visweshwar, M Jaglal, L Sokol, D Laber Blood Coagulation & Fibrinolysis 30 (5), 249-252, 2019 | 27 | 2019 |
| Spontaneous complete regression of hepatocellular carcinoma RE Storey, AL Huerta, A Khan, DA Laber Medical Oncology 28, 948-950, 2011 | 22 | 2011 |
| A phase I study of AGRO100 in advanced cancer DA Laber, MA Choudry, BS Taft, L Bhupalam, VR Sharma, FJ Hendler, ... Journal of Clinical Oncology 22 (14_suppl), 3112-3112, 2004 | 21 | 2004 |
| Metastatic microcystic adnexal carcinoma with DNA sequencing results and response to systemic antineoplastic chemotherapy MB Chen, DA Laber Anticancer Research 37 (9), 5109-5111, 2017 | 20 | 2017 |
| Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient C Sam, P Desai, D Laber, A Patel, N Visweshwar, M Jaglal Transfusion Medicine 27 (4), 300-302, 2017 | 20 | 2017 |
